ATAD1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| ATPase family, AAA domain containing 1 | MIM:614452 | Ensembl:ENSG00000138138 | HGNC:HGNC:25903 | PA134914940 | 10q23.31 |
GO terms in ATAD1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0005524 | ATP binding |
| MF | ISS | GO:0016887 | ATPase activity |
| BP | ISS | GO:0002092 | positive regulation of receptor internalization |
| BP | ISS | GO:0007612 | learning |
| BP | ISS | GO:0007613 | memory |
| BP | ISS | GO:0051967 | negative regulation of synaptic transmission, glutamatergic |
| CC | HDA | GO:0005778 | peroxisomal membrane |
| CC | HDA | GO:0016020 | membrane |
| CC | IEA | GO:0030054 | cell junction |
| CC | ISS | GO:0045211 | postsynaptic membrane |
Gene expression in normal tissue: ATAD1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ATAD1
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| smpdb | SMP00050 | Purine Metabolism |
| smpdb | SMP00144 | Adenosine Deaminase Deficiency |
| smpdb | SMP00167 | Adenylosuccinate Lyase Deficiency |
| smpdb | SMP00168 | AICA-Ribosiduria |
| smpdb | SMP00203 | Molybdenum Cofactor Deficiency |
| smpdb | SMP00210 | Purine Nucleoside Phosphorylase Deficiency |
| smpdb | SMP00220 | Xanthine Dehydrogenase Deficiency (Xanthinuria) |
| smpdb | SMP00364 | Lesch-Nyhan Syndrome (LNS) |
| smpdb | SMP00365 | Gout or Kelley-Seegmiller Syndrome |
| smpdb | SMP00427 | Azathioprine Action Pathway |
| smpdb | SMP00428 | Mercaptopurine Action Pathway |
| smpdb | SMP00430 | Thioguanine Action Pathway |
| smpdb | SMP00512 | Xanthinuria type I |
| smpdb | SMP00513 | Xanthinuria type II |
| smpdb | SMP00535 | Adenine phosphoribosyltransferase deficiency (APRT) |
| smpdb | SMP00536 | Mitochondrial DNA depletion syndrome |
| smpdb | SMP00537 | Myoadenylate deaminase deficiency |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ATAD1

